Abstract 16691: High-Dose versus Standard-Dose Influenza Vaccine in Older Adults with Neurological and Cerebrovascular Disease: A Prespecified Analysis of the DANFLU-2 Trial
Background: Adults with neurological or cerebrovascular (NeCVD) disease have an elevated risk of influenza-related complications. Whether HD-IIV provides greater relative benefit over SD-IIV in this population is uncertain. Objective: To evaluate the relative vaccine effectiveness (rVE) of high-dose inactivate...